Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Hemorrhage Control

Lessons Learned From the Battlefield Use of Hemostatic Agents That Can Be Applied in a Hospital Setting

Allison, Herman A. FNP-C, MSN, RN, CCEMT-Paramedic, PNCCT

doi: 10.1097/CNQ.0000000000000249
Original Articles

Uncontrolled blood loss is a major cause of preventable death worldwide. A severe injury can occur anywhere at any time. Controlling blood loss is an important issue for patient care in the hospital setting. Through the casualties of war, the lifesaving value of quick interventions was developed. Since 2001, new hemostatic agents have advanced the benefits of controlling blood loss. There are unforgettable lessons learned in the preventable deaths of many soldiers and should be passed on to the next generation of health care providers, to include all hospitals up to level I trauma hospitals. This article covers the current hemostatic agents that have been used for more than 17 years on the battlefield and are slowly making their way into the hospital settings. The hemostatic agents covered include QuikClot Combat Gauze, QuikClot Control+, WoundClot Hemostatic Gauze, HemCon Nasal Plug, and RevMedx's XSTAT hemostatic device. The standard of care should not be affected by the location of a patient, whether that patient is in a remote village overseas, on the battlefield, a rural farm, or at a major metropolitan hospital here in the United States.

SR-AHEC Family Practice Clinic, Fayetteville, North Carolina.

Correspondence: Herman A. Allison, FNP-C, MSN, RN, CCEMT-Paramedic, PNCCT, SR-AHEC Family Practice Clinic, 1601 Owen Dr, Fayetteville, NC 28304 (

Acknowledgment: To Lisa Kilburn, MLIS, AHIP, at Southern Regional AHEC for assisting me with the research and editing of this article.

I would like to dedicate this article to all the Americans who have died supporting the War on Terror all over the world since September 11, 2001.

The author has disclosed that he has no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved